EASL Clinical Practice Guidelines

Conflict of interest

Jean-Michel Pawlotsky: Grant and research support: Gilead. Advisory Boards: Abbvie, Achillion, Bristol-Myers Squibb, Gilead, Janssen, Merck. Speaking and teaching: Abbvie, Bristol-Myers Squibb, Gilead, Janssen, Merck, and Roche.

Alessio Aghemo: Advisory Boards: Abbvie, Gilead, Janssen, and Merck. Speaking and teaching: Abbvie, Bristol-Myers Squibb, Gilead, Janssen, Merck, and Roche.

David Back: Grant and research support: Abbvie, Bristol-Myers Squibb, Gilead, Janssen, Merck, and Viiv. Advisory Boards: Abbvie, Gilead, Janssen, and Merck. Speaking and teaching: Abbvie, Bristol-Myers Squibb, Gilead, Janssen, and Merck.

Geoffrey Dusheiko: Grant and research support: Abbvie, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Janssen, and Merck. Advisory Boards: Abbvie, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Janssen, and Merck. Speaking and teaching: Abbvie, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Janssen, and Merck.

Xavier Forns: Grant and research support: Janssen. Advisory Boards: Abbvie, Gilead, and Janssen. Speaking and teaching: Gilead, and Janssen.

Massimo Puoti: Grant and research support: Gilead. Advisory Boards: Abbvie, Bristol-Myers Squibb, Gilead, Janssen, and Merck. Speaking and teaching: Bristol-Myers Squibb, Gilead, Janssen, and Merck.

Christoph Sarrazin: Grant and research support: Abbott Molecular, Abbvie, Gilead, Janssen, Qiagen, Roche, and Siemens. Advisory Boards: Abbott Molecular, Abbvie, Achillion, Bristol-Myers Squibb, Gilead, Janssen, and Merck. Speaking and teaching: Abbott Molecular, Abbvie, Bristol-Myers Squibb, Gilead, Janssen, Merck, Qiagen, and Siemens.